1. New retinal findings in NLRP3-associated autoinflammatory disease
- Author
-
Zhangwanyu Wei, Zhikun Yang, Donghui Li, Xiao Zhang, Bing Li, Xufeng Zhao, Wenyu Yan, Bingxuan Wu, Na Wu, Xuqian Wang, Weihong Yu, and Min Shen
- Subjects
NLRP3-associated autoinflammatory disease (NLRP3-AID) ,Cryopyrin-associated periodic syndrome (CAPS) ,Retina ,Retinal vascular leakage ,Macular ischemia ,Microaneurysms ,Medicine - Abstract
Abstract Purpose To determine whether the rare NLRP3-Associated Autoinflammatory Disease (NLRP3-AID) is associated with retinal changes and to assess the ocular involvement. Methods A retrospective cohort study of 20 patients(40 eyes) diagnosed with rare NLRP3-AID at Peking Union Medical College Hospital, from April 2015 to August 2022. Patients underwent a comprehensive ophthalmological examination, including visual acuity, intraocular pressure examination, slit-lamp examination, fundus photography, optical coherence tomography(OCT), and fluorescence angiography (FA). Some patients also underwent optical coherence tomography angiography (OCTA). Results This study analyzed 40 eyes of 20 patients (11 [55.0%] male; median age, 25.0 years [range, 12–52 years]) and 13 patients (26 eyes, 65%) demonstrated ocular involvement. The most common ophthalmologic manifestation was conjunctivitis (22 eyes, 84.6%), followed by papilledema (14 eyes, 53.8%), retinopathy (10 eyes, 38.5%), optic atrophy (6 eyes, 23.1%), uveitis (4 eyes, 15.4%), reduced pupil light reflex (3 eyes, 11.5%) and cataracts (2 eyes, 7.7%). Ocular involvement was bilateral in 11 patients (55.0%). Five kinds of retinal lesions were seen in 5 patients (10 eyes, 25%) with NLRP3-AID, including peripheral retinal vascular leakage, microaneurysms, macular ischemia, macular epiretinal membrane formation and drusen. Conclusions Peripheral retinal vascular leakage, macular ischemia, microaneurysms and drusen are newly identified retinal findings in patients with NLRP3-AID, which suggests the importance of detailed retinal examination in these patients.
- Published
- 2023
- Full Text
- View/download PDF